藥 物 回 收
|
| |
| The United States: ABH NATURE’S PRODUCTS, INC, ABH PHARMA, INC., and STOCKNUTRA.COM, INC. issues nationwide recall of all lots of dietary supplement products (English Only) |
| |
The US Food and Drug Administration (FDA) announces that ABH NATURE’S PRODUCTS, INC, ABH PHARMA, INC., and STOCKNUTRA.COM, INC. (the “COMPANIES”) is conducting a nationwide recall of all lots of its dietary supplement products pursuant to a Consent Decree entered by the US District Court for the Eastern District of New York. This recall applies to all dietary supplement products manufactured and sold between January 2013 to November 2019 and all lots of products are included in this recall.
These products are being recalled after an FDA inspection found significant violations of current good manufacturing practice regulations. Manufacturing practices that are not in adequate control represent the possibility of risk being introduced into the manufacturing process resulting in finished supplement products with decreased identity, purity, strength and composition.
To date, there have been no reported illnesses or injuries as a result of this situation.
The COMPANIES contract manufactured dietary supplements for other firms and did not sell products directly to consumers.
Please refer to the following website in FDA for details:
http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/abh-natures-products-inc-abh-pharma-inc-and-stocknutracom-inc-issues-nationwide-recall-all-lots
In Hong Kong, there is no registered pharmaceutical product manufactured by ABH NATURE’S PRODUCTS, INC, ABH PHARMA, INC., and STOCKNUTRA.COM, INC.
Ends/Thursday, Jan 23, 2020
Issued at HKT 15:00
|
| |
